Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with 1H magnetic resonance spectroscopy

Metabolism: Clinical and Experimental

Volumn 58, Issue 12, 2009, Pages 1724-1730

  Mancini, Marcello ^a,b   Prinster, Anna ^a   Annuzzi, Giovanni ^c   Liuzzi, Raffaele ^a   Giacco, Rosalba ^d   Medagli, Carmela ^c   Cremone, Matteo ^c   Clemente, Gennaro ^d   Maurea, Simone ^c   Riccardi, Gabriele ^c   Rivellese, Angela Albarosa ^c   Salvatore, Marco ^c  

^a CNR   (Italy)

^b IRCCS SDN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d National Council of Research   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FAT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FATTY LIVER; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PILOT STUDY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADIPOSE TISSUE; ADULT; AGED; FATTY LIVER; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KIDNEY; LINEAR MODELS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PILOT PROJECTS; PROTONS; ROC CURVE; TRIGLYCERIDES;

EID: 71849117865     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.05.032     Document Type: Article

References (50)

1. Angulo P., and Lindor K.D. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 17 Suppl (2002) S186-S190
2. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395
3. Assy N., Kaita K., Mymin D., Levy C., Rosser B., and Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 45 (2000) 1929-1934
4. Ruderman N., Chisholm D., Pi-Sunyer X., and Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 47 (1998) 699-713
5. Silverman J.F., O'Brien K.F., Long S., et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 85 (1990) 1349-1355
6. Chitturi S., Abeygunasekera S., Farrell G.C., et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35 (2002) 373-379
7. Marchesini G., Brizi M., Morselli-Labate A.M., et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107 (1999) 450-455
8. Pagano G., Pacini G., Musso G., et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35 (2002) 367-372
9. Fracanzani A.L., Burdick L., Raselli S., et al. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med 121 (2008) 72-78
10. Brea A., Mosquera D., Martin E., Arizti A., Cordero J.L., and Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 25 (2005) 1045-1050
11. Luyckx F.H., Desaive C., Thiry A., et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 22 (1998) 222-226
12. Franzese A., Vajro P., Argenziano A., et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 42 (1997) 1428-1432
13. Schwimmer J.B., Deutsch R., Kahen T., Lavine J.E., Stanley C., and Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 118 (2006) 1388-1393
14. Bacon B.R., Farahvash M.J., Janney C.G., and Neuschwander-Tetri B.A. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107 (1994) 1103-1109
15. Diehl A.M., Goodman Z., and Ishak K.G. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95 (1988) 1056-1062
16. Mendler M.H., Bouillet P., Le Sidaner A., et al. Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol 28 (1998) 785-794
17. Kamel I.R., Kruskal J.B., Pomfret E.A., Keogan M.T., Warmbrand G., and Raptopoulos V. Impact of multidetector CT on donor selection and surgical planning before living adult right lobe liver transplantation. AJR Am J Roentgenol 176 (2001) 193-200
18. Wang B., Gao Z., Zou Q., and Li L. Quantitative diagnosis of fatty liver with dual-energy CT. An experimental study in rabbits. Acta Radiol 44 (2003) 92-97
19. Rosen B.R., Carter E.A., Pykett I.L., Buchbinder B.R., and Brady T.J. Proton chemical shift imaging: an evaluation of its clinical potential using an in vivo fatty liver model. Radiology 154 (1985) 469-472
20. Block R.E. Direct proton and natural abundance carbon-13 NMR observation of liver changes induced by ethionine. Biochem Biophys Res Commun 108 (1982) 940-947
21. Thomsen C., Becker U., Winkler K., Christoffersen P., Jensen M., and Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12 (1994) 487-495
22. Szczepaniak L.S., Nurenberg P., Leonard D., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288 (2005) E462-E468
23. Hoyumpa Jr. A.M., Greene H.L., Dunn G.D., and Schenker S. Fatty liver: biochemical and clinical considerations. Am J Dig Dis 20 (1975) 1142-1170
24. Longo R., Pollesello P., Ricci C., et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5 (1995) 281-285
25. Neuschwander-Tetri B.A., and Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37 (2003) 1202-1219
26. Szczepaniak L.S., Babcock E.E., Schick F., et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276 (1999) E977-E989
27. Cowin G.J., Jonsson J.R., Bauer J.D., et al. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 28 (2008) 937-945
28. Saadeh S., Younossi Z.M., Remer E.M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 745-750
29. Taylor K.J., Riely C.A., Hammers L., et al. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. Radiology 160 (1986) 65-71
30. Yang P.M., Huang G.T., Lin J.T., et al. Ultrasonography in the diagnosis of benign diffuse parenchymal liver diseases: a prospective study. Taiwan Yi Xue Hui Za Zhi 87 (1988) 966-977
31. Needleman L., Kurtz A.B., Rifkin M.D., Cooper H.S., Pasto M.E., and Goldberg B.B. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol 146 (1986) 1011-1015
32. Saverymuttu S.H., Joseph A.E., and Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 292 (1986) 13-15
33. Joseph A.E., Saverymuttu S.H., al-Sam S., Cook M.G., and Maxwell J.D. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 43 (1991) 26-31
34. Mottin C.C., Moretto M., Padoin A.V., et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 14 (2004) 635-637
35. Scatarige J.C., Scott W.W., Donovan P.J., Siegelman S.S., and Sanders R.C. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med 3 (1984) 9-14
36. Longo R., Ricci C., Masutti F., et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 28 (1993) 297-302
37. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res 6 Suppl 2 (1998) 51S-209S
38. Freese M., and Lyons E.A. Ultrasonic backscatter from human liver tissue: its dependence on frequency and protein/lipid composition. J Clin Ultrasound 5 (1977) 307-312
39. Kim S.H., Lee J.M., Kim J.H., et al. Appropriateness of a donor liver with respect to macrosteatosis: application of artificial neural networks to US images-initial experience. Radiology 234 (2005) 793-803
40. Osawa H., and Mori Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound 24 (1996) 25-29
41. Piccinino F., Sagnelli E., Pasquale G., and Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 2 (1986) 165-173
42. Belfort R., Harrison S.A., Brown K., et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 355 (2006) 2297-2307
43. Schwimmer J.B., Middleton M.S., Deutsch R., and Lavine J.E. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 21 (2005) 871-879
44. Petersen K.F., Dufour S., Befroy D., Lehrke M., Hendler R.E., and Shulman G.I. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54 (2005) 603-608
45. Tchelepi H., Ralls P.W., Radin R., and Grant E. Sonography of diffuse liver disease. J Ultrasound Med 21 (2002) 1023-1032 [quiz 1033-1034]
46. Rosenfield A.T., and Siegel N.J. Renal parenchymal disease: histopathologic-sonographic correlation. AJR Am J Roentgenol 137 (1981) 793-798
47. Hricak H., Cruz C., Romanski R., et al. Renal parenchymal disease: sonographic-histologic correlation. Radiology 144 (1982) 141-147
48. Mostbeck G., Derfler K., Walter R., Herold C., Mallek R., and Tscholakoff D. Ultrasound in terminal renal failure-etiologic conclusions?. Ultraschall Med 9 (1988) 250-254
49. Platt J.F., Rubin J.M., Bowerman R.A., and Marn C.S. The inability to detect kidney disease on the basis of echogenicity. AJR Am J Roentgenol 151 (1988) 317-319
50. Palmentieri B., de Sio I., La Mura V., et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 38 (2006) 485-489